Detalhe da pesquisa
1.
Carfilzomib vs bortezomib in patients with multiple myeloma and renal failure: a subgroup analysis of ENDEAVOR.
Blood
; 133(2): 147-155, 2019 01 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-30478094
2.
Incidence and risk of hypertension in patients newly treated for multiple myeloma: a retrospective cohort study.
BMC Cancer
; 16(1): 912, 2016 11 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-27876016
3.
A meta-analysis of efficacy and safety data from head-to-head first-line trials of epidermal growth factor receptor inhibitors versus bevacizumab in adult patients with RAS wild-type metastatic colorectal cancer by sidedness.
Eur J Cancer
; 202: 113975, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38442645
4.
Efficacy and safety of busulfan-based conditioning regimens for multiple myeloma.
Oncologist
; 18(5): 611-8, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23628980
5.
Recommendations on eliminating racial disparities in multiple myeloma therapies: a step toward achieving equity in healthcare.
Blood Cancer Discov
; 2(2): 119-124, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34179821
6.
B-cell maturation antigen (BCMA) in multiple myeloma: rationale for targeting and current therapeutic approaches.
Leukemia
; 34(4): 985-1005, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32055000
7.
How to Train Your T Cells: Overcoming Immune Dysfunction in Multiple Myeloma.
Clin Cancer Res
; 26(7): 1541-1554, 2020 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31672768
8.
Targeting MCL-1 in hematologic malignancies: Rationale and progress.
Blood Rev
; 44: 100672, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32204955
9.
Efficacy and safety of carfilzomib-based regimens in frail patients with relapsed and/or refractory multiple myeloma.
Blood Adv
; 4(21): 5449-5459, 2020 11 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33166401
10.
Once-weekly (70 mg/m2 ) vs twice-weekly (56 mg/m2 ) dosing of carfilzomib in patients with relapsed or refractory multiple myeloma: A post hoc analysis of the ENDEAVOR, A.R.R.O.W., and CHAMPION-1 trials.
Cancer Med
; 9(9): 2989-2996, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32108443
11.
A real-world comparative analysis of carfilzomib and other systemic multiple myeloma chemotherapies in a US community oncology setting.
Ther Adv Hematol
; 10: 2040620718816699, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-30719266
12.
Carfilzomib with immunomodulatory drugs for the treatment of newly diagnosed multiple myeloma.
Leukemia
; 33(9): 2127-2143, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31341235
13.
Cardiovascular events during carfilzomib therapy for relapsed myeloma: practical management aspects from two case studies.
Hematology
; 22(10): 585-591, 2017 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-28545322